Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Greg Moeck, PhD

Vice President, Microbiology
Venatorx Pharmaceuticals

Disclosure(s): Venatorx Pharmaceuticals: Employee, Stocks/Bonds

Poster(s):

590 - Activities of Cefepime-Taniborbactam and Ceftazidime-Avibactam against Cefepime-Resistant Respiratory Gram-Negative Pathogens in a Hollow Fiber Infection Model
Thursday, October 20, 2022
12:15 PM – 1:30 PM US ET